Catalyst
Slingshot members are tracking this event:
Mallinckrodt (MNK) to complete Phase 3 trial of IV Acetaminophen for the Treatment of Acute Pain in Pediatric Patients in 2016
- Source Link:
- https://clinicaltrials.gov/show/NCT01635101
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MNK |
|
|
||||
Additional Information
Study scheduled to be done Jan 2016, but still ongoing
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 10, 2016
Occurred Source:
https://clinicaltrials.gov/archive/NCT01635101
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Iv Acetaminophen, Phase 3 Study, Acute Pain, Acute Pain Management, Pediatric Study, Placebo-controlled
